Literature DB >> 7180028

Vaccine control of poliomyelitis in the 1980s.

A B Sabin.   

Abstract

The main challenge of vaccine control of poliomyelitis in the 1980s is in the subtropical and tropical regions of the world where "lameness" surveys in recent years have shown how very high the average annual incidence of paralytic poliomyelitis can be in both rural and urban areas in the absence of epidemics. The procedures by which oral polio vaccine (OPV) rapidly eliminated all or almost all paralytic disease caused by polioviruses from the economically developed temperate climate countries have been inadequate in tropical and subtropical countries, except in some small countries with good health services, largely because there is much more year-round circulation of "wild" polioviruses which continue to produce the disease in the unvaccinated and incompletely vaccinated children. Not even a cheap, hypothetically 100 percent effective, one-dose vaccine could eliminate poliomyelitis in the tropics if, for a variety of reasons, it would reach only a portion of the infant population. Paralytic disease caused by polioviruses has been quickly eliminated from both small and large tropical countries by OPV in well-organized programs of annual mass vaccinations of almost all children under a certain age.

Entities:  

Keywords:  Climate; Delivery Of Health Care; Developed Countries; Developing Countries; Diseases; Environment; Evaluation; Geographic Factors; Health; Health Services; Immunization; Incidence; Measurement; Medicine; Population; Preventive Medicine; Primary Health Care; Research Methodology; Spatial Distribution; Vaccination--administraction and dosage; Viral Diseases--prevention and control

Mesh:

Substances:

Year:  1982        PMID: 7180028      PMCID: PMC2596452     

Source DB:  PubMed          Journal:  Yale J Biol Med        ISSN: 0044-0086


  15 in total

1.  Poliomyelitis vaccination. Evaluation and direction in continuing application.

Authors:  A B Sabin
Journal:  Am J Clin Pathol       Date:  1978-07       Impact factor: 2.493

2.  Outbreak of paralytic illness of unknown etiology in Albacete, Spain.

Authors:  L Valenciano; E Nájera; F P Gallardo; A González; J Enrech
Journal:  Am J Epidemiol       Date:  1971-11       Impact factor: 4.897

3.  Vaccine-associated poliomyelitis cases.

Authors:  A B Sabin
Journal:  Bull World Health Organ       Date:  1969       Impact factor: 9.408

4.  Experiences of vaccination with inactivated poliovirus vaccine in Sweden.

Authors:  M Böttiger
Journal:  Dev Biol Stand       Date:  1981

5.  Poliomyelitis in the Netherlands.

Authors:  H Bijkerk
Journal:  Dev Biol Stand       Date:  1981

6.  [The poliomyelitis epidemic in 1978].

Authors:  H Bijkerk; F J Draaisma; A C van der Gugten; M van Os
Journal:  Ned Tijdschr Geneeskd       Date:  1979-09-23

7.  Paralytic syndromes associated with noninflammatory cytoplasmic or nuclear neuronopathy. Acute paralytic disease in Mexican children, neuropathologically distinguishable from Landry-Guillain-Barré syndrome.

Authors:  M Ramos-Alvarez; L Bessudo; A B Sabin
Journal:  JAMA       Date:  1969-02-24       Impact factor: 56.272

8.  Vaccination against poliomyelitis in economically underdeveloped countries.

Authors:  A B Sabin
Journal:  Bull World Health Organ       Date:  1980       Impact factor: 9.408

9.  Outside Europe. Is poliomyelitis a serious problem in developing countries?--the Danfa experience.

Authors:  D D Nicholas; J H Kratzer; S Ofosu-Amaah; D W Belcher
Journal:  Br Med J       Date:  1977-04-16

10.  Is poliomyelitis a serious problem in developing countries?--lameness in Ghanaian schools.

Authors:  S Ofosu-Amaah; J H Kratzer; D D Nicholas
Journal:  Br Med J       Date:  1977-04-16
View more
  3 in total

Review 1.  Perspectives on rapid elimination and ultimate global eradication of paralytic poliomyelitis caused by polioviruses.

Authors:  A B Sabin
Journal:  Eur J Epidemiol       Date:  1991-03       Impact factor: 8.082

2.  Lessons from the eradication of smallpox: an interview with D. A. Henderson.

Authors:  D A Henderson; Petra Klepac
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2013-06-24       Impact factor: 6.237

3.  Chapter 4 Picornavirus infections.

Authors: 
Journal:  Perspect Med Virol       Date:  2008-05-29
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.